Tag

Amyloid Beta Protein

All articles tagged with #amyloid beta protein

health-medicine1 year ago

"Link Between Decades-Old Medical Treatments and Alzheimer's Transmission Uncovered"

A recent study suggests a potential link between past medical treatment with contaminated human growth hormone and the early onset of Alzheimer’s disease in five individuals, highlighting the importance of preventing accidental amyloid-beta transmission in medical procedures. The study reports that individuals treated with cadaver-derived human growth hormone (c-hGH) between 1959 and 1985 may have developed Alzheimer's disease due to transmission of the amyloid-beta protein. The findings underscore the need to review measures to prevent accidental transmission of amyloid-beta via other medical or surgical procedures and may provide valuable insights into disease mechanisms for understanding and treating Alzheimer’s disease in the future.

health1 year ago

"Link Between Hormone Treatment and Transmitted Alzheimer's Uncovered"

A study published in Nature Medicine has found evidence linking cadaver-derived human growth hormone (c-hGH) treatment to the development of Alzheimer's disease, marking the first direct connection between a specific medical treatment and the illness. Researchers at University College London (UCL) discovered that c-hGH, no longer used due to safety concerns, can increase levels of the amyloid-beta protein in the brain, a hallmark of Alzheimer's. While the study only identified a small number of patients affected, it raises concerns about potential risks associated with certain medical treatments and suggests the need for further research to confirm these findings.

health1 year ago

"Link Between Medical Procedures and Alzheimer's Transmission Revealed in New Study"

A study published in Nature Medicine by researchers from University College London (UCL) has linked growth hormone treatments to the development of Alzheimer’s disease, specifically a now-obsolete form of human growth hormone extracted from the pituitary glands of deceased people. The study found that this treatment led to greater amounts of amyloid-beta protein in the brain, triggering symptoms of dementia in some patients. While the transmission of Alzheimer’s disease through medical procedures is extremely rare, the findings emphasize the importance of understanding and preventing potential risks associated with pathogen transmission.

neuroscience2 years ago

Blood biomarker may link Alzheimer's and hearing loss.

Researchers found a correlation between Alzheimer's disease plaques and hearing loss in mice, with the location of amyloid beta protein plaques being a critical factor. Plaques on the auditory brainstem impeded the area's ability to coordinate responses to sound, potentially explaining why some Alzheimer's patients experience auditory symptoms. This finding could offer a new approach to tracking Alzheimer's disease progression and inform diagnostic practices, as the location of plaques may be more important to hearing decline and could be a potential biomarker to track disease progression.

health2 years ago

Nose-picking linked to Alzheimer's in mouse study.

A study conducted on mice by scientists from Griffith University in Australia suggests that nose-picking could increase the chances of developing Alzheimer's disease. The study found that when internal tissues are damaged due to nose-picking, critical species of bacteria gain an easier path to the brain, which responds to the bacteria's presence in ways that resemble signs of Alzheimer's disease. The research is based on mice, and further investigation is needed to confirm the same pathway operates in humans. The study highlights the importance of protecting nose tissue and avoiding nose-picking.

neuroscience2 years ago

Sleeping Pills Could Halt Alzheimer's Progression, Study Suggests

A small study has shown that suvorexant, a sleep medication commonly prescribed to treat insomnia, reduced levels of the Alzheimer’s-associated amyloid beta protein and hyperphosphorylated tau protein in the brain. The study suggests that sleep medications could slow or stop the progression of Alzheimer’s disease, but more research is needed to confirm the viability of such an approach.